Other companies don't sell them. They bailed for various reasons, and the expense of getting in just isn't worth it. If you develop an EpiPen and it costs you

Other companies don't sell them. They bailed for various reasons, and the expense of getting in just isn't worth it. If you develop an EpiPen and it costs you a bunch of money then in theory you can make it up by selling more volume. Except your competitor can just cut the price because they are already selling for an absurd amount of money, so how do you win now? Maybe we should have a non-profit that does generic versions, and we can subsidize it by preferring them to companies like this (e.g. all medicare provided drugs now go through this company which sells generics). Unless the companies are willing to match prices.